| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Coya Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 140,041 | 22 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COYA | Coya Therapeutics, Inc. | 22 Jan 2026 | 1 | $0 | 4 | Chief Financial Officer | 26 Jan 2026, 08:00 |
| COYA | Coya Therapeutics, Inc. | 09 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 13 Jan 2025, 08:00 |
| COYA | Coya Therapeutics, Inc. | 14 Nov 2024 | 1 | +$12,934 | 4 | Chief Financial Officer | 14 Nov 2024, 18:08 |
| COYA | Coya Therapeutics, Inc. | 03 Jun 2024 | 1 | $0 | 4 | Chief Financial Officer | 05 Jun 2024, 20:00 |
| COYA | Coya Therapeutics, Inc. | 02 Feb 2024 | 1 | $0 | 4 | Chief Financial Officer | 02 Feb 2024, 20:00 |
| COYA | Coya Therapeutics, Inc. | 27 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 01 Mar 2023, 15:05 |
| COYA | Coya Therapeutics, Inc. | 03 Jan 2023 | 2 | $0 | 4 | Chief Financial Officer | 04 Jan 2023, 07:30 |
| COYA | Coya Therapeutics, Inc. | 28 Dec 2022 | 0 | $0 | 3 | Chief Financial Officer | 28 Dec 2022, 19:47 |